(2025), who, in their seven-year follow-up of adolescent LSG patients, observed sustained benefits but also noted modest weight regain in some cases, emphasizing the ongoing need for individualized care and potentially, adjunctive strategies to maintain optimal results [11]
Right now, the only oral GLP-1 medication available is Rybelsus, an oral form of semaglutide thats FDA-approved for type 2 diabetes but not yet for weight loss
Gastroenterology 141:150156 Gier B, Matveyenko AV, Kirakossian D, Dawson D, Dry SM, Butler PC (2012) Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model
During your consultation, well evaluate your medical background, lifestyle, and weight loss goals to determine if these injections are a safe and appropriate solution
Van Ness KP, McHugh TE, Bammler TK, Eaton DL
Consistency and Policy: Having a clear and consistent policy on B12 injection schedules ensures that all patients receive the same standard of care and that staff are not put in a position to make ad-hoc decisions
